A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Clinical trial NCT01163253 · TERMINATED
Trial details
- NCT number
- NCT01163253
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2016-06-01
- Enrollment
- 2867
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.